We studied the contribution of NEDD9 to glioma progression and invasiveness using real-time PCR to analyze mRNA expression levels in 18 GB specimens, 18 GB-NS cell lines and 27 LGG specimens previously investigated for expression of miR-145. This evidence concerns the gene NEDD9 and central nervous system cancer.